Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03490253 · ClinicalTrials.gov registry record · NA
Diabetes and Depression Text Messaging Intervention
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 226
- Enrollment target
NCT03490253 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 226 participants.
The verdict
NCT03490253, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 226 participants
- Enrollment target
Study Summary
The main aim of the "Diabetes and Mental Health Adaptive Notification Tracking and Evaluation" trial (DIAMANTE) is to test a smartphone intervention that generates adaptive messaging, learning from daily patient data to personalize the timing and type of text-messages. We will compare the adaptive content to 1. a static messaging intervention with health management and educational messages and 2. a control condition that receives a weekly mood message. The primary outcomes for this aim will be improvements in physical activity at 6-month follow-up defined by daily step counts.
Interventions
- BEHAVIORAL DIAMANTE Adaptive
- BEHAVIORAL DIAMANTE Static
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2020-02-05 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03490253
The ClinicalTrials.gov registry entry for NCT03490253 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DIAMANTE Adaptive is the first listed.
NCT03490253 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03490253 about?
NCT03490253 is a clinical study titled "Diabetes and Depression Text Messaging Intervention". The main aim of the "Diabetes and Mental Health Adaptive Notification Tracking and Evaluation" trial (DIAMANTE) is to test a smartphone intervention that generates adaptive messaging, learning from daily patient data to personalize the timing and type of text-messages. We will compare the adaptive c...
What is the current status of trial NCT03490253?
This trial is currently completed. It is a NA study. The enrollment target is 226 participants. The study started on 2020-02-05. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT03490253?
The interventions under investigation include: DIAMANTE Adaptive (BEHAVIORAL), DIAMANTE Static (BEHAVIORAL).
Who is sponsoring clinical trial NCT03490253?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.